Outcomes of Anti-BCMA CAR T Cell Therapy for Relapsed/refractory Multiple Myeloma: A Meta-Analysis

被引：0
|
作者：
Gagelmann, Nico [1 ]
Ayuk, Francis [1 ]
Atanackovic, Djordje [2 ]
Kroeger, Nicolaus [1 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
[2] Univ Utah, Salt Lake City, UT USA
来源：
BONE MARROW TRANSPLANTATION | 2020年 / 55卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O122
引用
收藏
页码：130 / 130
页数：1
相关论文
共 50 条
  • [31] Cost-Effectiveness of Anti-BCMA Chimeric Antigen Receptor T Cell Therapy in Relapsed/Refractory Multiple Myeloma
    Yamamoto, Chihiro
    Minakata, Daisuke
    Yokoyama, Daizo
    Furuki, Shuka
    Noguchi, Atsuto
    Koyama, Shunsuke
    Oyama, Takashi
    Murahashi, Rui
    Nakashima, Hirotomo
    Ikeda, Takashi
    Kawaguchi, Shin-ichiro
    Hyodo, Kazuki
    Toda, Yumiko
    Ito, Shoko
    Nagayama, Takashi
    Umino, Kento
    Morita, Kaoru
    Ashizawa, Masahiro
    Ueda, Masuzu
    Hatano, Kaoru
    Sato, Kazuya
    Ohmine, Ken
    Fujiwara, Shin-ichiro
    Kanda, Yoshinobu
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (01): : 118.e1 - 118.e15
  • [32] Anti-BCMA CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma Patients With Extramedullary Disease: A Single Center Analysis of Two Clinical Trials
    Que, Yimei
    Xu, Menglei
    Xu, Yanjie
    Almeida, Varlene Daniela Fernandes
    Zhu, Li
    Wang, Zhiqiong
    Wang, Ying
    Liu, Xian
    Jiang, Lijun
    Wang, Di
    Li, Chunrui
    Zhou, Jianfeng
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [33] The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple Myeloma
    Manjunath, Shwetha H.
    Cohen, Adam D.
    Lacey, Simon F.
    Davis, Megan M.
    Garfall, Alfred L.
    Melenhorst, J. Joseph
    Maxwell, Russell
    Arscott, W. Tristram
    Maity, Amit
    Jones, Joshua A.
    Plastaras, John P.
    Stadtmauer, Edward A.
    Levine, Bruce L.
    June, Carl H.
    Milone, Michael C.
    Paydar, Ima
    CLINICAL CANCER RESEARCH, 2021, 27 (23) : 6580 - 6590
  • [34] Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple Myeloma
    Costa, Luciano J.
    Lin, Yi
    Cornell, R. Frank
    Martin, Thomas
    Chhabra, Saurabh
    Usmani, Saad Z.
    Jagannath, Sundar
    Callander, Natalie S.
    Berdeja, Jesus G.
    Kang, Yubin
    Vij, Ravi
    Godby, Kelly N.
    Malek, Ehsan
    Neppalli, Amarendra
    Liedtke, Michaela
    Fiala, Mark
    Tian, Hong
    Valluri, Satish
    Marino, Jennifer
    Jackson, Carolyn C.
    Banerjee, Arnob
    Kansagra, Ankit
    Schecter, Jordan M.
    Kumar, Shaji
    Hari, Parameswaran
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (05): : 326 - 335
  • [35] Hematopoietic reconstitution and infections after anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma are associated with pre-CAR-T bridging therapies
    Frenking, Jan
    Kauer, Joseph
    Hajiyianni, Marina
    Mai, Elias
    Michel, Christian
    Sester, Lilli
    John, Lukas
    Mueller-Tidow, Carsten
    Goldschmidt, Hartmut
    Weinhold, Niels
    Schmitt, Anita
    Schmitt, Michael
    Dreger, Peter
    Sauer, Sandra
    Raab, Marc
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S38 - S39
  • [36] Incidence of Parkinsonism As a Complication of Anti-BCMA CAR-T Cell Therapy in Multiple Myeloma
    Singh, Vaishnavi
    Master, Samip
    BLOOD, 2023, 142
  • [37] Anti-BCMA CAR T-cell Therapy: Changing the Natural History of Multiple Myeloma
    Puertas, Borja
    Mateos, Maria-Victoria
    Gonzalez-Calle, Veronica
    HEMASPHERE, 2022, 6 (03):
  • [38] A Phase Ib/II Study of Trovocabtagene Autoleucel (C-CAR088), an Anti-BCMA CAR T-Cell Therapy in Relapsed or Refractory Multiple Myeloma
    An, Gang
    Xu, Yan
    Yi, Shuhua
    Lyu, Rui
    Huang, Jiaqi
    Li, Wensi
    Zhang, Yiran
    Lan, Liping
    Qiu, Lugui
    BLOOD, 2024, 144 : 7235 - 7236
  • [39] Safety and Efficacy of Anti-Bcma CAR-T Cells for Relapsed/Refractory Multiple Myeloma: A Systematic Review of Literature
    Khan, Israr
    Rafae, Abdul
    Javaid, Anum
    Ahmed, Zahoor
    Qadeer, Haifza Abeera
    Khan, Sana Irfan
    Dar, Abdul Jabbar
    Khurshid, Qasim
    Jaan, Ali
    Khalid, Farhan
    Aijaz, Zobia
    Hashmi, Mydah Sajid
    Malik, Mustafa Nadeem
    Anwer, Faiz
    BLOOD, 2020, 136
  • [40] sBCMA Plasma Level Dynamics and Anti-BCMA CAR-T-Cell Treatment in Relapsed Multiple Myeloma
    Seipel, Katja
    Porret, Naomi
    Wiedemann, Gertrud
    Jeker, Barbara
    Bacher, Vera Ulrike
    Pabst, Thomas
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2022, 44 (04) : 1463 - 1471
12345